Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model

Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model

Background and aims Bacteriotherapy aimed at addressing dysbiosis may be therapeutic for Inflammatory Bowel Diseases (IBDs). We sought to determine if defined Bacteroides-based bacteriotherapy could be an effective and consistent alternative to fecal microbiota transplantation (FMT) in a murine mode...

Full description

Bibliographic Details
Main Authors: Faith D. Ihekweazu, Tatiana Y. Fofanova, Karen Queliza, Dorottya Nagy-Szakal, Christopher J. Stewart, Melinda A. Engevik, Kristina G. Hulten, Nina Tatevian, David Y. Graham, James Versalovic, Joseph F. Petrosino, Richard Kellermayer
Format: Article
Language:English
Published: Taylor & Francis Group 2019-07-01
Series:Gut Microbes
Subjects:
inflammatory bowel disease
bacteriotherapy
bacteroides
microbiota
dysbiosis
fecal microbiota transplantation
Online Access:http://dx.doi.org/10.1080/19490976.2018.1560753

Internet

http://dx.doi.org/10.1080/19490976.2018.1560753

Similar Items